Skip to main content

Posts from December 2014

What challenges were seen in competitive R&D and clinical stages? What outcomes were measured in related trials? Does the drug I am creating have potential efficacy or safety challenges? What does the patient population look like?

These are the sort of critical business questions that many life science researchers need to answer. And now, there’s a solution that can help you.

We all know the importance of high quality content you can depend on when it comes to making key business decisions across the pharma life cycle. We also know that the best way to get from textual data to new insights is using natural language processing-based text analytics. And that’s where our partnership with Thomson Reuters comes in. We’ve worked together on a solution to bring Linguamatics market-leading text mining platform, I2E, together with Thomson Reuters Cortellis high-quality clinical and epidemiology content: Cortellis Informatics Clinical Text Analytics for I2E.

Cortellis Informatics Clinical Text Analytics for I2E applies the power of natural language processing-based text mining from Linguamatics I2E to Cortellis clinical and epidemiology content sets. Taking this approach allows users to rapidly extract relevant information using the advanced search capabilities of I2E. The solution also allows users to identify concepts using a rich set of combined vocabularies from Thomson Reuters and Linguamatics.

Philadelphia, PA, December 4, 2014

Cortellis Informatics Clinical Text Analytics for I2E combines industry’s most powerful text analytics with the most comprehensive source of life sciences reference information.

The Intellectual Property & Science business of Thomson Reuters, the world leader in intelligent information for businesses and professionals, today announced a collaboration with Linguamatics to advance pharmaceutical clinical trial research and development (R&D) with the launch of  CortellisTM Informatics Clinical Text Analytics for I2E.

The new solution, available through Thomson Reuters Cortellis—the most powerful intelligence platform for life science professionals—applies Linguamatics I2E text mining platform to relevant information to assist researchers in finding actionable insights.

The content includes clinical trial information, epidemiology data, literature, press releases and conference proceedings. 

Cortellis Informatics Clinical Text Analytics for I2E uses the combination of Linguamatics’ powerful, market-leading NLP text analytics platform with the largest breadth and depth of integrated clinical content available.

Through a single interface, users will be able to glean new insights in support of trials, site selection and competitive intelligence, helping them to design more effective clinical trials and gain a deeper understanding of the implications of their results.

“We are excited about this innovative project with Thomson Reuters” said John Brimacombe, executive chairman of Linguamatics.

Ready to get started?

Request a demo

Questions? Ask our experts